Activation of rapid oestrogen signalling in aggressive human breast cancers

EMBO Molecular Medicine - Tập 4 Số 11 - Trang 1200-1213 - 2012
Coralie Poulard1, Isabelle Treilleux1, Emilie Lavergne2, Katia Bouchekioua‐Bouzaghou1, Sophie Goddard‐Léon3, Sylvie Chabaud2, Olivier Trédan4, Laura Corbo1, Muriel Le Romancer1
1Université de Lyon, Lyon, France
2Biostatistics Unit, Centre Léon Bérard, Lyon, France
3Pathology Department, Centre Léon Bérard, Lyon, France
4Department of Medical Oncology, Centre Léon Bérard, Lyon, France

Tóm tắt

AbstractOestrogen receptors can mediate rapid activation of cytoplasmic signalling cascades by recruiting Src and PI3K. However, the involvement of this pathway in breast cancer remains poorly defined. We have previously shown that methylation of ERα is required for the formation of the ERα/Src/PI3K complex and that ERα is hypermethylated in a subset of breast cancers. Here, we used Proximity Ligation Assay to demonstrate that this complex is present in the cytoplasm of breast cancer cell lines as well as formalin‐fixed, paraffin‐embedded tumours. Of particular interest, the analysis of 175 breast tumours showed that overexpression of this complex in a subset of breast tumours correlates to the activation of the downstream effector Akt. Survival analysis revealed that high expression of this complex is an independent marker of poor prognosis and associated with reduced disease‐free survival. Our data introduces the new concept that the rapid oestrogen pathway is operative in vivo. It also provides a rationale for patient stratification defined by the activation of this pathway and the identification of target therapies.

Từ khóa


Tài liệu tham khảo

10.1128/MCB.23.1.335-348.2003

10.1016/j.ctrv.2010.02.015

10.1210/me.2003-0335

10.1016/S0140-6736(02)09088-8

10.1242/jcs.01025

10.1093/annonc/mdr261

10.1093/emboj/20.21.6050

10.1007/s10549-010-1024-7

10.1091/mbc.E03-11-0823

10.1158/1078-0432.CCR-11-0288

10.1056/NEJMra1001389

10.2174/157489210789702208

10.1210/er.2007-0022

10.1074/jbc.M005036200

Jensen EV, 2003, The estrogen receptor: a model for molecular medicine, Clin Cancer Res, 9, 1980

10.1038/nrc1211

10.1038/nature00889

10.1210/er.2010-0016

10.1016/j.steroids.2010.01.013

10.1016/j.molcel.2008.05.025

10.1016/j.tem.2009.06.009

MacGregor JI, 1998, Basic guide to the mechanisms of antiestrogen action, Pharmacol Rev, 50, 151

10.1016/0092-8674(95)90199-X

10.1158/1078-0432.CCR-09-1834

10.1016/S0092-8674(02)00641-4

10.1038/nrc2713

10.1038/265069a0

10.1210/me.2004-0115

10.1210/me.2010-0252

10.1038/sj.onc.1208076

10.1038/35035131

10.1038/nmeth947

10.1016/j.tem.2005.06.010

10.1146/annurev.bi.63.070194.002315

10.1158/1541-7786.MCR-07-0150

10.1016/j.steroids.2005.09.001

10.1677/ERC-10-0136

10.1158/1078-0432.CCR-11-1236

10.1007/s10147-008-0818-7

Thông tin
Thông tin xuất bản

EMBO Molecular Medicine

Tập 4 Số 11

1200-1213

Thông tin tác giả